Filing Details

Accession Number:
0000905718-21-001545
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-29 16:30:55
Reporting Period:
2021-11-24
Accepted Time:
2021-11-29 16:30:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1692830 Satsuma Pharmaceuticals Inc. STSA Pharmaceutical Preparations (2834) 813039831
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831942 Commodore Capital Lp 767 Fifth Ave
12Th Floor
New York NY 10153
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2021-11-24 2,922 $5.42 3,711,286 No 4 P Indirect By Commodore Capital Master LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Commodore Capital Master LP
Footnotes
  1. The shares are held directly by Commodore Capital Master LP ("Commodore Master"). Commodore Capital LP ("Commodore Capital") is the investment manager to Commodore Master. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Capital and exercise investment and dispositive power over the securities held by Commodore Master. Each of Commodore Capital, Mr. Kramarz and Mr. Atkinson disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that Commodore Capital, Commodore Master, Mr. Kramarz and Mr. Atkinson or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.37 to $5.50 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.